The disposition of indomethacin in preterm babies

The Journal of Pediatrics

Volumn 97, Issue 6, 1980, Pages 1001-1006

  Yaffe, Summer J ^a,b,c,d,e   Friedman, F ^a,b,c,d,e   Rogers, Douglas ^a,b,c,d,e   Lang, Peter ^a,b,c,d,e   Ragni, Marie ^a,b,c,d,e   Saccar, Connie ^a,b,c,d,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

CARDIOVASCULAR SYSTEM; CONGENITAL DISORDER; DRUG BLOOD LEVEL; DUCTUS ARTERIOSUS; HEART; MAJOR CLINICAL STUDY; NEWBORN; PHARMACOKINETICS; PREMATURITY;

AGE FACTORS; DUCTUS ARTERIOSUS, PATENT; FEMALE; HALF-LIFE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INJECTIONS, INTRAVENOUS; KINETICS; MALE; METABOLIC CLEARANCE RATE; SEX FACTORS;

EID: 0019159204     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(80)80446-X     Document Type: Article

References (24)

1. Pharmacologic closure of patent ductus arteriosus in the premature infant
2. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis
3. Closure of the patent ductus arteriosus with ligation and indomethacin A consecutive experience
4. Indomethacin therapy for large patent ductus arteriosus in the very low birthweight infant: Results and complications
5. Failure of indomethacin therapy to induce closure of patent ductus arteriosus in premature infants with respiratory distress syndrome
6. Failure of indomethacin to close persistent ductus arteriosus in infants weighing under 1000 grams
7. Prostaglandins: Physiological and clinical correlations
8. Patent ductus arteriosus
9. 1 is a potent relaxant of the fetal ductus arteriosus
10. Disposition of indomethacin in preterm infants
11. Medical management of small preterm infants with symptomatic patent ductus arteriosus
12. Indomethacin estimation in plasma and serum by electrocapture gas chromatography
13. Determination of indomethacin in serum and urine by electron-capture gas-liquid chromatography
14. Pharmacokinetics of oral and intravenous indomethacin in pre-term infants
15. Pharmacokinetics of indomethacin in the premature infant
16. Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man
17. Pharmacokinetics of indomethacin
18. Zur pharmakokinetik von indomethacin bei Schwangren, Kreissenden, und deren neugelorenen
19. Zur pharmakokinetik von indomethacin in abhangigkeit von lebensalter, bei patienten mit gallenwegervershiluss, nierenfunktionseinschrankung und unvertraglich-kertserscheinungen
20. Indomethacin disposition and indomethacin-induced platelet dysfunction in premature infants
21. Plasma indomethacin levels in preterm newborn infants with symptomatic patent ductus arteriosus-clinical and echocardiographic assessments of response
22. Indomethacin and renal function in premature infants with persistent patent ductus arteriosus
23. The influence of indomethacin on neonatal renal function